Nick Haft

Nick Haft is a Co-Founder and Managing Director of OMX Ventures, a venture capital firm focused on life sciences and bio-engineering. He previously founded and managed Arcos Ventures, deploying over $80 million across more than 20 bio-related companies. He also co-founded Delix Therapeutics, a company developing novel treatments for psychiatric and neurological disorders. He holds a Bachelor of Science in Economics from The Wharton School.

His professional focus is deeply intertwined with a passion for advancing human health. He actively invests in and helps build companies tackling major challenges, from mental health disorders through his work with Delix to infant nutrition, which he has publicly supported. This indicates a personal commitment to improving wellness through scientific innovation.

He co-founded Delix Therapeutics, which is developing non-hallucinogenic versions of psychedelic compounds to treat mental health conditions, aiming to provide safer, more scalable therapies.